Benign prostatic hyperplasia: A progressive disease of aging men

被引:167
|
作者
Emberton, M
Andriole, GL
de la Rosette, J
Djavan, B
Hoefner, K
Navarrete, RV
Nordling, J
Roehrborn, C
Schulman, C
Teillac, P
Tubaro, A
Nickel, JC
机构
[1] UCL, Inst Urol & Nephrol, London W1P 3AA, England
[2] Washington Univ, Sch Med, Div Urol, St Louis, MO USA
[3] St Radboud, Univ Med Ctr, Ctr Minimal Invas Urol, Nijmegen, Netherlands
[4] Univ Vienna, Dept Urol, Vienna, Austria
[5] Hannover Med Sch, Dept Urol, D-3000 Hannover, Germany
[6] Univ Autonoma Madrid, Fdn Jimenez Diaz, Madrid, Spain
[7] Univ Copenhagen, Herlev Hosp, Dept Urol, DK-2730 Herlev, Denmark
[8] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX USA
[9] Univ Clin Brussels, Erasme Hosp, Brussels, Belgium
[10] St Louis Univ, Ctr Hosp, Paris, France
[11] Univ Aquila, Sch Med, Dept Urol, I-67100 Laquila, Italy
[12] Queens Univ, Dept Urol, Kingston, ON, Canada
关键词
D O I
10.1016/S0090-4295(02)02371-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:267 / 273
页数:7
相关论文
共 50 条
  • [21] Men's theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid
    Holmes-Rovner, M
    Price, C
    Rovner, DR
    Kelly-Bloke, K
    Lillie, J
    Wills, C
    Bonham, VL
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (01) : 56 - 60
  • [22] Men’s theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid
    Margaret Holmes-Rovner
    Chrystal Price
    David R. Rovner
    Karen Kelly-Blake
    Janet Lillie
    Celia Wills
    Vence L. Bonham
    Journal of General Internal Medicine, 2006, 21 : 56 - 60
  • [23] Benign prostatic hyperplasia and metabolic syndrome: the expanding evidences of a new disease of aging male
    Russo, Giorgio I.
    Cimino, Sebastiano
    Morgia, Giuseppe
    AGING MALE, 2015, 18 (03): : 133 - 134
  • [24] Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men
    Weisman, KM
    Larijani, GE
    Goldstein, MR
    Goldberg, ME
    PHARMACOTHERAPY, 2000, 20 (04): : 383 - 386
  • [25] Benign prostatic hyperplasia: a new metabolic disease?
    Vignozzi, L.
    Rastrelli, G.
    Corona, G.
    Gacci, M.
    Forti, G.
    Maggi, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (04): : 313 - 322
  • [26] MEASURING DISEASE-SPECIFIC HEALTH-STATUS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
    BARRY, MJ
    FOWLER, FJ
    OLEARY, MP
    BRUSKEWITZ, RC
    HOLTGREWE, HL
    MEBUST, WK
    MEDICAL CARE, 1995, 33 (04) : AS145 - AS155
  • [27] Benign prostatic hyperplasia: a new metabolic disease?
    L. Vignozzi
    G. Rastrelli
    G. Corona
    M. Gacci
    G. Forti
    M. Maggi
    Journal of Endocrinological Investigation, 2014, 37 : 313 - 322
  • [28] ETIOLOGY AND DISEASE PROCESS OF BENIGN PROSTATIC HYPERPLASIA
    ISAACS, JT
    COFFEY, DS
    PROSTATE, 1989, : 33 - 50
  • [29] Benign prostatic hyperplasia may be an epigenetic disease
    Moon, W
    Kim, TY
    Kim, YS
    Oh, MR
    Noh, CH
    JOURNAL OF UROLOGY, 2006, 175 (04): : 467 - 467
  • [30] Benign Prostatic Hyperplasia and Incident Cardiovascular Disease
    Suzuki, Yuta
    Kaneko, Hidehiro
    Okada, Akira
    Fujiu, Katsuhito
    Jo, Taisuke
    Takeda, Norifumi
    Tanaka, Atsushi
    Node, Koichi
    Morita, Hiroyuki
    Yasunaga, Hideo
    Komuro, Issei
    CIRCULATION JOURNAL, 2024, 88 (03) : 408 - 416